يستعمل دواء جليبتالينا 500/2.5 مجم 30 قرصgliptalina 2.5/500mg 30 f.c. tabs. anti-diabetic.secretagogues.dpp-4 inhibitors anti-diabetic.secretagogues.dpp-4 inhibitors

this is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults: - -as monotherapy - - in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance or contraindicated due to renal impairment. - -as combination therapy - - in combination with metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - in combination with a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - in combination with insulin with or without metformin when this regimen alone with diet and exercise does not provide adequate glycaemic control.